|Articles|March 31, 2023
- Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Advertisement
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5






















